AVILA THERAPEUTICS INC — Form D

AVILA THERAPEUTICS INC of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-05-14. The offering totals $20.0M, of which $5.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
Bruce BoothDirectorCambridge, MA
Raj ParekhDirectorWaltham, MA
Daniel LynchDirectorGreenfield, IN
Daniel LynchExecutive OfficerGreenfield, IN
AMIR NASHATDirectorSan Diego, CA
KATRINE BOSLEYDirectorCAMBRIDGE, MA
KATRINE BOSLEYExecutive OfficerCAMBRIDGE, MA
Vicki SatoDirectorSan Francisco, CA
HENRY SKINNERDirectorSAN DIEGO, CA
Michael F BighamDirectorLondon, X0
Michael F BighamExecutive OfficerLondon, X0
Roy R LobbDirectorWellesley, MA
Roy R LobbExecutive OfficerWellesley, MA
Henry R SkinnerDirectorWaltham, MA
Amir R NashatDirectorWaltham, MA
Raj R ParekhDirectorWaltham, MA
Bruce F BoothDirectorWaltham, MA
Vicki R SatoDirectorWaltham, MA
Daniel R LynchDirectorWaltham, MA

Other filings by this issuer (2)

FiledFormOfferingSold
2010-07-06D/A$30.0M$22.5M
2009-07-31D$30.0M$17.5M

More